A detailed history of Osborne Partners Capital Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Osborne Partners Capital Management, LLC holds 28,553 shares of TMO stock, worth $14.7 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
28,553
Previous 28,874 1.11%
Holding current value
$14.7 Million
Previous $16 Million 10.6%
% of portfolio
1.01%
Previous 0.97%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$531.86 - $624.21 $170,727 - $200,371
-321 Reduced 1.11%
28,553 $17.7 Million
Q2 2024

Jul 22, 2024

BUY
$541.52 - $599.02 $4,332 - $4,792
8 Added 0.03%
28,874 $16 Million
Q1 2024

Apr 25, 2024

BUY
$528.82 - $599.43 $278,688 - $315,899
527 Added 1.86%
28,866 $16.8 Million
Q4 2023

Jan 22, 2024

BUY
$431.41 - $532.94 $366,267 - $452,466
849 Added 3.09%
28,339 $15 Million
Q3 2023

Oct 26, 2023

BUY
$498.29 - $574.41 $145,500 - $167,727
292 Added 1.07%
27,490 $13.9 Million
Q2 2023

Jul 20, 2023

BUY
$508.46 - $591.13 $326,939 - $380,096
643 Added 2.42%
27,198 $14.2 Million
Q1 2023

Apr 24, 2023

BUY
$535.0 - $604.82 $111,815 - $126,407
209 Added 0.79%
26,555 $15.3 Million
Q4 2022

Jan 24, 2023

BUY
$484.71 - $571.37 $132,325 - $155,984
273 Added 1.05%
26,346 $0
Q3 2022

Oct 27, 2022

BUY
$507.19 - $604.49 $197,296 - $235,146
389 Added 1.51%
26,073 $13.2 Million
Q2 2022

Aug 01, 2022

SELL
$500.9 - $612.21 $446,802 - $546,091
-892 Reduced 3.36%
25,684 $14 Million
Q1 2022

May 05, 2022

BUY
$524.0 - $644.92 $406,624 - $500,457
776 Added 3.01%
26,576 $15.7 Million
Q4 2021

Jan 31, 2022

SELL
$569.0 - $667.24 $14,794 - $17,348
-26 Reduced 0.1%
25,800 $17.2 Million
Q3 2021

Oct 25, 2021

BUY
$509.53 - $609.78 $44,329 - $53,050
87 Added 0.34%
25,826 $14.8 Million
Q2 2021

Aug 09, 2021

BUY
$441.0 - $508.24 $211,239 - $243,446
479 Added 1.9%
25,739 $13 Million
Q1 2021

Aug 09, 2021

BUY
$439.85 - $518.83 $69,936 - $82,493
159 Added 0.63%
25,260 $11.5 Million
Q1 2021

Apr 27, 2021

BUY
$439.85 - $518.83 $157,026 - $185,222
357 Added 1.44%
25,101 $11.5 Million
Q4 2020

Feb 01, 2021

SELL
$435.06 - $527.66 $3.38 Million - $4.1 Million
-7,768 Reduced 23.89%
24,744 $11.5 Million
Q3 2020

Oct 28, 2020

SELL
$359.77 - $441.52 $389,630 - $478,166
-1,083 Reduced 3.22%
32,512 $14.4 Million
Q2 2020

Jul 23, 2020

SELL
$275.2 - $362.34 $310,976 - $409,444
-1,130 Reduced 3.25%
33,595 $12.2 Million
Q1 2020

Apr 29, 2020

BUY
$255.3 - $340.05 $144,499 - $192,468
566 Added 1.66%
34,725 $9.85 Million
Q4 2019

Jan 27, 2020

SELL
$271.93 - $328.04 $851,956 - $1.03 Million
-3,133 Reduced 8.4%
34,159 $11.1 Million
Q3 2019

Oct 25, 2019

SELL
$268.46 - $305.43 $191,143 - $217,466
-712 Reduced 1.87%
37,292 $10.9 Million
Q2 2019

Jul 18, 2019

SELL
$257.51 - $295.55 $161,716 - $185,605
-628 Reduced 1.63%
38,004 $11.2 Million
Q1 2019

Apr 24, 2019

SELL
$212.17 - $273.72 $178,222 - $229,924
-840 Reduced 2.13%
38,632 $10.6 Million
Q4 2018

Jan 28, 2019

SELL
$208.47 - $251.98 $93,186 - $112,635
-447 Reduced 1.12%
39,472 $8.83 Million
Q3 2018

Oct 26, 2018

SELL
$205.57 - $244.32 $2.82 Million - $3.35 Million
-13,708 Reduced 25.56%
39,919 $9.74 Million
Q2 2018

Jul 19, 2018

SELL
$203.14 - $219.53 $874,923 - $945,515
-4,307 Reduced 7.43%
53,627 $11.1 Million
Q1 2018

Apr 19, 2018

SELL
$192.98 - $224.11 $29,718 - $34,512
-154 Reduced 0.27%
57,934 $12 Million
Q4 2017

Jan 25, 2018

SELL
$182.03 - $200.37 $463,812 - $510,542
-2,548 Reduced 4.2%
58,088 $11 Million
Q3 2017

Oct 19, 2017

BUY
$171.74 - $194.04 $10.4 Million - $11.8 Million
60,636
60,636 $11.5 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Osborne Partners Capital Management, LLC Portfolio

Follow Osborne Partners Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.